Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL334886 | 0.80 | ALDH1A1 (0.35) | MEN1ALDH1A1HTTKMT2AHIF1A | |
| SCHEMBL8080248 | 0.80 | DGAT1 (0.36) | DGAT1 | |
| SCHEMBL16828345 | 0.79 | ALDH1A1 (0.34) | MEN1ALDH1A1HTTKMT2AHIF1A | |
| SCHEMBL20184262 | 0.78 | — | — | |
| SCHEMBL8843634 | 0.77 | MEN1 (0.36) | MEN1ALDH1A1HTTKMT2AHIF1A | |
| SCHEMBL334562 | 0.73 | MAPK1 (0.32) | MEN1ALDH1A1HTTKMT2AHIF1A | |
| SCHEMBL16828348 | 0.73 | ALDH1A1 (0.36) | MEN1ALDH1A1HTTKMT2AHIF1A | |
| SCHEMBL7105703 | 0.73 | ALDH1A1 (0.33) | MEN1ALDH1A1HTTKMT2AHIF1A | |
| SCHEMBL332010 | 0.72 | — | — | |
| SCHEMBL11007623 | 0.72 | MEN1 (0.30) | MEN1ALDH1A1HTTKMT2AHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1091 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12473688-B2 | Carbene co-grafting modified fabric, preparation and application thereof | SOOCHOW UNIVERSITY (CN) | 2025-11-18 | — | — | US | claimed |
| US-20250092008-A1 | PROCESS FOR MAKING AN EP4 ANTAGONIST | ONO PHARMACEUTICAL CO., LTD. (JP) | 2025-03-20 | — | — | US | claimed |
| CN-118930436-A | Method for catalyzing coupling reaction of nitro compound and diazo compound by using corrinyl ring-containing small molecular compound | 北京化工大学 | 2024-11-12 | — | — | CN | claimed |
| US-20240344265-A1 | CARBENE CO-GRAFTING MODIFIED FABRIC, PREPARATION AND APPLICATION THEREOF | SOOCHOW UNIVERSITY (CN) | 2024-10-17 | — | — | US | claimed |
| EP-4384509-A1 | PROCESS FOR MAKING AN EP4 ANTAGONIST | ONO Pharmaceutical Co., Ltd. (JP) | 2024-06-19 | — | — | EP | claimed |
| CN-117265554-A | Method for preparing thioester derivative by electrocatalytic reaction | 江苏中利集团股份有限公司 | 2023-12-22 | — | — | CN | claimed |
| CN-117105874-A | Preparation method of N-alkoxyl acyl methyl substituted-1, 2, 3-triazole | 曲阜师范大学 | 2023-11-24 | — | — | CN | claimed |
| WO-2023155368-A1 | CARBENE CO-GRAFTED MODIFIED FABRIC, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | 苏州大学 | 2023-08-24 | — | — | WO | claimed |
| WO-2023017813-A1 | PROCESS FOR MAKING AN EP4 ANTAGONIST | ONO PHARMACEUTICAL CO., LTD. (JP) | 2023-02-16 | — | — | WO | claimed |
| CN-114481608-B | Carbene co-grafting modified fabric and preparation method and application thereof | 苏州大学 | 2022-12-30 | — | — | CN | claimed |
| US-20030073849-A1 | Cyclopropylindole derivatives as selective serotonin reuptake inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2003-04-17 | — | — | US | claimed |
| US-20030013696-A1 | Methods and compositions for photo-cross linking photoactive compounds to target tissue | BRITISH COLUMBIA, UNIVERSITY OF, THE (CA) | 2003-01-16 | — | — | US | claimed |
| WO-2002079152-A1 | CYCLOPROPYLINDOLE DERIVATIVES AS SELECTIVE SEROTONIN REUPTAKE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-10-10 | — | — | WO | claimed |
| WO-2002076453-A1 | METHODS AND COMPOSITIONS FOR PHOTO-CROSS LINKING PHOTOACTIVE COMPOUNDS TO TARGET TISSUE | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2002-10-03 | — | — | WO | claimed |
| EP-0594608-B1 | CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESIS | RES CORP TECHNOLOGIES INC (US) | 1997-10-15 | — | — | EP | claimed |
| EP-0594608-A1 | CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESIS. | RES CORP TECHNOLOGIES INC (US) | 1994-05-04 | — | — | EP | claimed |
| US-5296595-A | Metal complexes with bridging ligands | RESEARCH CORPORATION TECHNOLOGIES (US) | 1994-03-22 | — | — | US | claimed |
| EP-0594608-A4 | CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESIS. | RES CORP TECHNOLOGIES INC (US) | 1993-03-15 | — | — | EP | claimed |
| US-5175311-A | Reacting olefin with carbene precursor | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1992-12-29 | — | — | US | claimed |
| WO-1991014672-A1 | CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESIS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1991-10-03 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030073849-A1 | Cyclopropylindole derivatives as selective serotonin reuptake inhibitors | HTR5A, HTR1A, HTR2C | MEN1 3485/4885ALDH1A1 961/4885HTT 763/4885 |
| US-20250092008-A1 | PROCESS FOR MAKING AN EP4 ANTAGONIST | PTGER4, LTB4R2, EPB41 | MEN1 4691/4885ALDH1A1 1405/4885HTT 4791/4885 |
| US-20030013696-A1 | Methods and compositions for photo-cross linking photoactive compounds to target tissue | LCP1, PPOX, TYR | MEN1 4224/4885ALDH1A1 542/4885HTT 2959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.